No Licence Renewal For Blood Centres Sans Hospital

Dehradun: All blood centres operating outside of hospitals in Uttarakhand will no longer be eligible for licence renewal, a circular issued on Saturday by the Uttarakhand Food and Drug Authority (FDA) said.

Currently, 82 blood centres are operational in the state, and this directive is expected to impact 30-35 of them, a source in the department said. However, centres run by organisations like Indian Medical Association (IMA) or those under Red Cross will not be affected, as they are classified as charity organisations, according to officials.

Existing centres with a five-year licence will not have to establish a hospital, but once the licences expire, they will not be renewed unless they have moved into hospital premises.

Tajber Singh, additional commissioner, state Food and Drug Administration, said, “Affiliation with any hospital won’t help. Blood centres must be within hospital premises, to ensure that patients in need of blood and plasma receive priority. It also promotes strict preservation of blood as per protocols.”

The move is expected to curb high prices charged by private blood banks during crises and to address issues of incorrect blood transfusions by promoting proper testing and storage of blood.

Related Posts

Gene Therapy for Cholesterol: Initial Test Results Cheer

Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states